Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Myomics Q

K-Number: K211432 · 2021-11-23

ApplicantPhantomics, Inc.
Decision Date2021-11-23
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Myomics Q is a medical device manufactured by Phantomics, Inc.. It received FDA 510(k) clearance on 2021-11-23 under approval number K211432. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Myomics Q?

Myomics Q is a medical device that received FDA 510(k) clearance on 2021-11-23. It is manufactured by Phantomics, Inc.. The 510(k) number is K211432.

When was Myomics Q approved by the FDA?

Myomics Q received FDA 510(k) clearance on 2021-11-23, under approval number K211432.

What company makes Myomics Q?

Myomics Q is manufactured by Phantomics, Inc..

What is the FDA product code for Myomics Q?

The FDA product code for Myomics Q is LLZ.

Other Devices by Phantomics, Inc.

K241922Myomics

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑